Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
TENX	TENAX THERAPEUTICS INC	$327.85M	-56.30%	-53.10%	-50.49%	2,352.30%	0.07	14.52	N/A	N/A	N/A
GENB	GENERATE BIOMEDICINES INC	$1.79B	N/A	N/A	N/A	N/A	0.22	9.17	N/A	N/A	N/A
PYXS	PYXIS ONCOLOGY INC	$122.91M	-135.60%	-85.00%	-168.21%	-96.30%	1.06	2.76	82.80%	-589.80%	-579.80%
MIRM	MIRUM PHARMACEUTICALS INC	$6.14B	-289.30%	-98.50%	-126.69%	-194.30%	2.67	2.09	81.40%	-140.20%	-137.47%
OM	OUTSET MEDICAL INC	$78.97M	-55.90%	-27.70%	-28.45%	-20.50%	1.23	6.29	40.60%	-63.70%	-51.25%
CTEV	CLARITEV CORP	$401.48M	N/A	-5.80%	0.52%	0.50%	-21.04	1.28	73.20%	-29.30%	2.45%
IMMX	IMMIX BIOPHARMA INC	$471.75M	-73.20%	-59.20%	-40.99%	8,512.30%	0.14	8.76	N/A	N/A	N/A
EVO	EVOTEC SE	$1.06B	-24.50%	-11.20%	-13.52%	-14.00%	1.34	1.68	11.50%	-26.00%	-22.08%
TRVI	TREVI THERAPEUTICS INC	$2.01B	-24.50%	-23.40%	-26.48%	-34.10%	0.04	24.75	N/A	N/A	N/A
LGVN	LONGEVERON INC	$22.46M	-202.40%	-140.70%	-132.99%	-3,670.90%	0.32	3.88	65.10%	-1,844.50%	-1,844.49%
OCS	OCULIS HOLDING AG	$1.92B	-56.80%	-45.60%	-47.03%	-99.90%	0.24	5.18	100.00%	-7,889.60%	-7,850.54%
NUVL	NUVALENT INC	$8.00B	-42.80%	-37.80%	-35.96%	-47.80%	0.13	16.14	N/A	N/A	N/A
JBIO	JADE BIOSCIENCES INC	$1.16B	-51.30%	-47.30%	-43.59%	-86.20%	0.08	14.29	N/A	N/A	N/A
LUNG	PULMONX CORP	$65.05M	-92.90%	-39.80%	-48.70%	-51.40%	1.62	4.91	75.50%	-60.10%	-55.59%
CATX	PERSPECTIVE THERAPEUTICS INC	$441.36M	-41.80%	-34.60%	-29.42%	-50.50%	0.18	8.75	100.00%	-17,982.70%	-18,053.88%
ENVB	ENVERIC BIOSCIENCES INC	$8.17M	-311.30%	-250.00%	-162.43%	2,501.60%	0.09	11.67	N/A	N/A	N/A
CELC	CELCUITY INC	$6.95B	-244.60%	-50.20%	-45.85%	-34.30%	6.66	12.31	N/A	N/A	N/A
FRMM	FORUM MARKETS INC	$70.97M	-244.40%	-136.80%	-267.83%	-147.80%	0.23	6.19	100.00%	-5,575.30%	-5,532.18%
EDIT	EDITAS MEDICINE INC	$261.41M	-677.40%	-58.20%	-101.07%	-167.00%	32.88	3.22	100.00%	-281.60%	-286.17%
STSS	SHARPS TECHNOLOGY INC	$79.99M	-166.40%	-162.70%	-207.45%	-172.40%	0.01	8.28	92.10%	-3,586.20%	-3,588.33%
TARA	PROTARA THERAPEUTICS INC	$279.34M	-38.70%	-36.00%	-34.59%	-44.50%	0.06	15.69	N/A	N/A	N/A
ISPC	ISPECIMEN INC	$5.13M	-584.70%	-142.50%	-1,099.45%	244.50%	7.12	0.62	-29.60%	-1,080.70%	-1,080.72%
ABSI	ABSCI CORP	$793.56M	-63.60%	-54.70%	-67.32%	-92.70%	0.14	6.59	100.00%	-6,450.80%	-6,437.75%
SCLX	SCILEX HOLDING CO	$50.27M	N/A	-164.90%	176.30%	280.10%	-2.16	0.08	59.70%	-1,239.40%	-1,083.57%
MPLT	MAPLIGHT THERAPEUTICS INC	$1.33B	N/A	N/A	N/A	N/A	0.05	22.91	N/A	N/A	N/A
VTGN	VISTAGEN THERAPEUTICS INC	$25.24M	-109.70%	-89.60%	-130.12%	-918.60%	0.28	4.68	100.00%	-8,486.80%	-8,486.84%
GLUE	MONTE ROSA THERAPEUTICS INC	$1.59B	-41.00%	-25.90%	-19.82%	-39.40%	0.41	9.54	100.00%	-302.70%	-307.04%
SPRB	SPRUCE BIOSCIENCES INC	$145.05M	-155.40%	-101.70%	-82.16%	1,096.50%	0.62	4.67	N/A	N/A	N/A
NMRA	NEUMORA THERAPEUTICS INC	$342.78M	-181.70%	-119.20%	-175.90%	-430.60%	1.18	5.10	N/A	N/A	N/A
UPB	UPSTREAM BIO INC	$460.39M	-43.80%	-42.30%	-51.50%	-55.90%	0.05	23.14	100.00%	-4,719.00%	-4,718.96%
OBIO	ORCHESTRA BIOMED HOLDINGS INC	$245.51M	-158.10%	-60.40%	-60.37%	-73.50%	1.21	7.03	99.50%	-167.60%	-160.44%
BCAX	BICARA THERAPEUTICS INC	$1.37B	-35.90%	-33.80%	-30.55%	-85.50%	0.08	13.85	N/A	N/A	N/A
DNA	GINKGO BIOWORKS HOLDINGS INC	$527.82M	-57.30%	-26.60%	-32.03%	-24.40%	1.33	5.15	73.10%	-215.40%	-216.12%
MAIA	MAIA BIOTECHNOLOGY INC	$77.82M	-284.80%	-142.90%	-83.62%	413.60%	0.27	5.59	N/A	N/A	N/A
GHRS	GH RESEARCH PLC	$1.35B	-19.80%	-19.10%	-21.27%	-151.30%	0.05	23.04	N/A	N/A	N/A
MYO	MYOMO INC	$36.71M	-114.90%	-40.80%	-48.63%	-46.30%	3.08	2.73	66.00%	-36.70%	-32.30%
RCUS	ARCUS BIOSCIENCES INC	$3.00B	-69.00%	-35.30%	-45.56%	-51.60%	0.90	4.04	100.00%	-156.40%	-152.12%
QSI	QUANTUM-SI INC	$215.58M	-47.30%	-42.70%	-51.27%	-51.50%	0.06	12.60	40.00%	-5,605.90%	-5,609.94%
JAGX	JAGUAR HEALTH INC	$2.09M	N/A	-115.60%	1,023.95%	-172.70%	-3.75	0.50	85.10%	-169.50%	-112.61%
SION	SIONNA THERAPEUTICS INC	$1.89B	-27.30%	-25.90%	-28.98%	-31.10%	0.06	22.60	N/A	N/A	N/A
ELTX	ELICIO THERAPEUTICS INC	$188.95M	-2,748.20%	-151.10%	-251.11%	-271.50%	-16.79	2.24	N/A	N/A	N/A
RXRX	RECURSION PHARMACEUTICALS INC	$1.65B	-54.30%	-40.60%	-46.65%	-311.60%	0.31	5.47	7.20%	-842.90%	-849.83%
CNTB	CONNECT BIOPHARMA HOLDINGS LTD	$148.59M	-122.30%	-97.10%	-149.73%	-482.50%	0.41	3.23	100.00%	-27,727.90%	-27,645.92%
ARVN	ARVINAS INC	$587.14M	-44.40%	-28.40%	-41.57%	-41.20%	0.67	5.44	100.00%	-247.50%	-247.20%
PRAX	PRAXIS PRECISION MEDICINES INC	$9.77B	-43.00%	-40.20%	-23.16%	-71.10%	0.04	15.88	N/A	N/A	N/A
HRTX	HERON THERAPEUTICS INC	$164.86M	-1,115.30%	-12.60%	-14.95%	-10.00%	25.95	2.53	71.10%	-20.50%	-15.45%
BEAT	HEARTBEAM INC	$51.07M	-1,034.00%	-434.40%	-3,185.98%	2,184.20%	5.19	0.74	N/A	N/A	N/A
DFTX	DEFINIUM THERAPEUTICS INC	$2.47B	-102.50%	-70.70%	-72.28%	-153.80%	0.44	4.69	N/A	N/A	N/A
ACRV	ACRIVON THERAPEUTICS INC	$76.62M	-64.40%	-57.10%	-79.84%	-89.80%	0.13	8.98	N/A	N/A	N/A
EIKN	EIKON THERAPEUTICS INC	$604.19M	N/A	N/A	N/A	N/A	0.55	11.75	N/A	N/A	N/A
SGP	SPYGLASS PHARMA INC	$737.21M	N/A	N/A	N/A	N/A	0.03	38.00	N/A	N/A	N/A
CYPH	CYPHERPUNK TECHNOLOGIES INC	$139.47M	-92.40%	-80.70%	-67.26%	-113.10%	0.04	27.28	N/A	N/A	N/A
AVBP	ARRIVENT BIOPHARMA INC	$1.26B	-49.00%	-45.40%	-44.79%	-68.00%	0.08	13.95	N/A	N/A	N/A
TMDX	TRANSMEDICS GROUP INC	$2.38B	41.90%	15.80%	7.95%	9.40%	1.90	6.74	59.10%	27.00%	16.80%
CVKD	CADRENAL THERAPEUTICS INC	$14.83M	-411.00%	-275.60%	-661.53%	1,138.50%	0.59	2.68	N/A	N/A	N/A
AKBA	AKEBIA THERAPEUTICS INC	$273.62M	-62.70%	-5.70%	1.24%	5.70%	12.24	1.40	81.00%	-8.80%	1.01%
FULC	FULCRUM THERAPEUTICS INC	$439.11M	-27.80%	-26.30%	-22.59%	-38.20%	0.04	34.33	N/A	N/A	N/A
DRTS	ALPHA TAU MEDICAL LTD	$964.59M	-57.30%	-42.40%	-44.90%	-44.40%	0.37	7.45	N/A	N/A	N/A
SYRE	SPYRE THERAPEUTICS INC	$6.45B	-31.20%	-27.80%	-26.43%	-36.20%	0.14	8.97	N/A	N/A	N/A
IVA	INVENTIVA SA	$1.01B	N/A	-192.20%	-79.70%	-87.70%	-9.75	3.16	100.00%	-4,468.10%	-1,730.94%
AMLX	AMYLYX PHARMACEUTICALS INC	$1.55B	-55.70%	-50.70%	-54.05%	-158.90%	0.08	17.85	N/A	N/A	N/A
COGT	COGENT BIOSCIENCES INC	$5.57B	-83.30%	-55.80%	-41.42%	-67.00%	0.49	15.14	N/A	N/A	N/A
ALT	ALTIMMUNE INC	$569.81M	-42.60%	-35.60%	-27.25%	-51.40%	0.18	29.56	100.00%	-253,002.80%	-245,494.44%
ACOG	ALPHA COGNITION INC	$126.73M	-54.10%	-41.80%	-38.00%	-508.80%	0.21	12.64	84.40%	-232.20%	-224.05%
ERAS	ERASCA INC	$3.61B	-77.00%	-64.30%	-63.75%	-71.80%	0.17	9.52	N/A	N/A	N/A
NNOX	NANO-X IMAGING LTD	$132.92M	-47.10%	-41.70%	-53.85%	-122.40%	0.16	3.96	-98.20%	-576.10%	-600.83%
LNSR	LENSAR INC	$72.02M	-183.20%	42.30%	60.70%	114.00%	3.86	2.38	45.70%	50.90%	50.94%
SNDA	SONIDA SENIOR LIVING INC	$1.80B	-51.00%	-9.60%	-2.48%	-3.00%	1.96	0.44	22.00%	-30.10%	-13.84%
OGI	ORGANIGRAM GLOBAL INC	$154.21M	-6.80%	-4.60%	-8.99%	-14.40%	0.40	2.82	35.60%	-9.20%	-14.18%
ARTL	ARTELO BIOSCIENCES INC	$3.10M	-1,602.50%	-225.00%	-195.28%	324.80%	0.88	1.79	N/A	N/A	N/A
OCUL	OCULAR THERAPEUTIX INC	$1.80B	-64.60%	-48.40%	-40.72%	-296.40%	0.26	14.81	87.20%	-558.20%	-535.90%
AHG	AKSO HEALTH GROUP	$1.29B	-68.00%	-63.80%	-83.31%	-193.00%	0.07	1.53	1.00%	-914.10%	-1,122.78%
IMTX	IMMATICS NV	$1.51B	-47.10%	-39.10%	-44.13%	-108.70%	0.19	8.78	100.00%	-574.90%	-577.38%
ALDX	ALDEYRA THERAPEUTICS INC	$95.91M	-57.30%	-36.30%	-60.44%	-576.70%	0.58	2.72	N/A	N/A	N/A
OWLT	OWLET INC	$166.47M	N/A	-62.50%	-111.12%	-369.70%	2.42	1.71	50.90%	-45.30%	-40.08%
FEED	ENVUE MEDICAL INC	$5.67M	-101.10%	-80.30%	-75.13%	1,046.50%	0.25	0.90	-12.40%	-1,720.50%	-1,136.91%
LRMR	LARIMAR THERAPEUTICS INC	$370.86M	-134.10%	-96.00%	-103.27%	-449.60%	0.32	4.29	N/A	N/A	N/A
NERV	MINERVA NEUROSCIENCES INC	$246.92M	N/A	-662.80%	-463.54%	-601.20%	-1.35	17.65	N/A	N/A	N/A
ABCL	ABCELLERA BIOLOGICS INC	$1.57B	-14.90%	-10.60%	-14.11%	-14.50%	0.39	14.05	100.00%	-181.70%	-224.46%
GNLX	GENELUX CORP	$130.93M	-174.60%	-123.60%	-133.79%	-207.60%	0.41	3.68	N/A	N/A	N/A
CTMX	CYTOMX THERAPEUTICS INC	$818.56M	-38.50%	-29.40%	-18.11%	-41.50%	0.12	10.38	100.00%	-174.80%	-165.74%
GANX	GAIN THERAPEUTICS INC	$74.64M	-201.40%	-136.20%	-136.66%	1,668.10%	0.34	4.69	N/A	N/A	N/A
OSUR	ORASURE TECHNOLOGIES INC	$226.51M	-21.50%	-18.20%	-21.86%	-62.60%	0.21	5.46	42.20%	-66.40%	-64.81%
CRDL	CARDIOL THERAPEUTICS INC	$146.55M	-229.20%	-165.40%	-149.71%	997.90%	0.30	4.39	N/A	N/A	N/A
MLYS	MINERALYS THERAPEUTICS INC	$2.49B	-27.90%	-27.00%	-23.78%	-38.70%	0.02	44.33	N/A	N/A	N/A
NKTX	NKARTA INC	$216.78M	-30.90%	-24.20%	-28.24%	-23.70%	0.30	12.96	N/A	N/A	N/A
CLDX	CELLDEX THERAPEUTICS INC	$2.40B	-50.70%	-46.60%	-61.69%	-55.90%	0.12	8.92	100.00%	-32,753.60%	-32,753.58%
OSRH	OSR HOLDINGS INC	$17.90M	-21.40%	-10.50%	-13.19%	200.60%	0.43	0.16	22.20%	-707.50%	-774.73%
ICU	SEASTAR MEDICAL HOLDING CORP	$15.83M	-146.30%	-96.50%	-162.24%	593.30%	0.54	2.73	93.10%	-828.60%	-826.46%
TNGX	TANGO THERAPEUTICS INC	$3.13B	-41.50%	-33.40%	-25.45%	-44.90%	0.11	27.38	100.00%	-188.20%	-188.20%
FBLG	FIBROBIOLOGICS INC	$5.47M	-767.10%	-195.60%	-449.55%	-376.50%	1.28	1.59	N/A	N/A	N/A
IKT	INHIBIKASE THERAPEUTICS INC	$229.74M	-41.30%	-39.00%	-30.40%	-108.00%	0.03	30.14	N/A	N/A	N/A
TRDA	ENTRADA THERAPEUTICS INC	$244.96M	-51.20%	-42.20%	-52.21%	-48.90%	0.24	13.90	100.00%	-2,895.10%	-2,878.29%
TNXP	TONIX PHARMACEUTICALS HOLDING CORP	$223.17M	-67.70%	-60.50%	-64.57%	-349.20%	0.14	6.99	58.60%	-839.50%	-839.52%
ONCY	ONCOLYTICS BIOTECH INC	$94.29M	N/A	-322.30%	-1,208.00%	1,534.50%	-2.59	1.38	N/A	N/A	N/A
ONCO	ONCONETIX INC	$1.40M	-109.00%	-51.10%	-77.94%	128.70%	0.26	1.41	79.60%	-1,364.20%	-1,247.44%
BBNX	BETA BIONICS INC	$472.80M	-23.00%	-20.60%	-23.62%	-24.40%	0.12	10.69	57.20%	-60.30%	-60.27%
DYN	DYNE THERAPEUTICS INC	$2.87B	-58.30%	-46.80%	-42.90%	-114.60%	0.25	19.92	N/A	N/A	N/A
BCTX	BRIACELL THERAPEUTICS CORP	$26.97M	-174.50%	-140.80%	-99.17%	-849.10%	0.11	10.10	N/A	N/A	N/A
CMPX	COMPASS THERAPEUTICS INC	$347.57M	-39.70%	-35.30%	-34.98%	-45.10%	0.10	19.04	N/A	N/A	N/A

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	602	+0.98%	-2.57%	-1.90%	-76.05%	18.28x	4.87x	-122.61%	-12.79%	-9.65%	+63.30%	Strong Buy
Diagnostics & Research	55	+0.67%	+2.81%	-8.17%	+10.83%	15.48x	3.33x	-6.63%	+6.21%	+12.47%	+27.83%	Strong Buy
Drug Manufacturers - General	20	+1.56%	+1.86%	+5.32%	+34.81%	35.69x	7.08x	+34.51%	+12.30%	+21.70%	+16.21%	Buy
Drug Manufacturers - Specialty & Generic	75	+1.45%	+0.08%	-0.21%	-29.54%	10.90x	1.56x	+9.35%	+5.09%	+10.99%	+40.37%	Buy
Healthcare Plans	10	-0.67%	-2.56%	+17.39%	-0.56%	26.31x	2.31x	+9.02%	+2.82%	+6.93%	+0.78%	Buy
Health Information Services	53	-0.32%	+2.09%	+1.61%	-27.61%	18.03x	2.95x	-3.94%	+0.71%	+1.12%	+39.60%	Buy
Medical Care Facilities	50	-0.91%	-2.48%	+4.38%	-21.64%	15.15x	4.82x	-49.93%	+6.78%	+15.36%	+22.72%	Buy
Medical Devices	139	+0.14%	+3.57%	-2.51%	-69.30%	23.09x	3.04x	+6.44%	+5.41%	+9.00%	+33.12%	Strong Buy
Medical Distribution	10	+1.07%	+2.30%	-9.07%	+5.35%	22.37x	143.42x	-104.83%	+3.78%	+25.68%	+28.40%	Buy
Medical Instruments & Supplies	55	+0.20%	+3.38%	-1.50%	-5.73%	42.68x	3.27x	+7.01%	+7.29%	+10.77%	+27.03%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in May 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Bioventus (NASDAQ:BVS)

Bioventus (NASDAQ:BVS) is the #1 top healthcare stock out of 1069 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Bioventus (NASDAQ:BVS) is: Value: A, Growth: A, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Bioventus (NASDAQ:BVS) has a Due Diligence Score of 47, which is 20 points higher than the healthcare sector average of 27. It passed 15 out of 33 due diligence checks and has strong fundamentals. Bioventus has seen its stock return 42.55% over the past year, overperforming other healthcare stocks by 102 percentage points.

Bioventus has an average 1 year price target of $15.00, an upside of 57.98% from Bioventus's current stock price of $9.50.

Bioventus stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Bioventus, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the #2 top healthcare stock out of 1069 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Jazz Pharmaceuticals (NASDAQ:JAZZ) is: Value: A, Growth: A, Momentum: B, Sentiment: C, Safety: C, Financials: B, and AI: C.

Jazz Pharmaceuticals (NASDAQ:JAZZ) has a Due Diligence Score of 34, which is 7 points higher than the healthcare sector average of 27. It passed 11 out of 33 due diligence checks and has average fundamentals. Jazz Pharmaceuticals has seen its stock return 122.45% over the past year, overperforming other healthcare stocks by 181 percentage points.

Jazz Pharmaceuticals has an average 1 year price target of $251.09, an upside of 4.88% from Jazz Pharmaceuticals's current stock price of $239.40.

Jazz Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 11 analysts covering Jazz Pharmaceuticals, 72.73% have issued a Strong Buy rating, 27.27% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Indivior Pharmaceuticals (NASDAQ:INDV)

Indivior Pharmaceuticals (NASDAQ:INDV) is the #3 top healthcare stock out of 1069 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Indivior Pharmaceuticals (NASDAQ:INDV) is: Value: B, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Indivior Pharmaceuticals (NASDAQ:INDV) has a Due Diligence Score of 41, which is 14 points higher than the healthcare sector average of 27. It passed 14 out of 33 due diligence checks and has strong fundamentals. Indivior Pharmaceuticals has seen its stock return 234.79% over the past year, overperforming other healthcare stocks by 294 percentage points.

Indivior Pharmaceuticals has an average 1 year price target of $48.00, an upside of 28.14% from Indivior Pharmaceuticals's current stock price of $37.46.

Indivior Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Indivior Pharmaceuticals, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 75 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Cryo Cell International (NYSEMKT:CCEL)

Cryo Cell International (NYSEMKT:CCEL) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 2.66%.

Cryo Cell International's dividend payout ratio of -45.5% indicates that its dividend yield might not be sustainable for the long-term.

2. So Young International (NASDAQ:SY)

So Young International (NASDAQ:SY) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 2.66%.

So Young International's dividend payout ratio of 0% indicates that its dividend yield might not be sustainable for the long-term.

3. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 30.19%, which is 28 percentage points higher than the healthcare sector average of 2.66%.

Dominari Holdings's dividend payout ratio of -19.1% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.58% in the last day, and up 0.01% over the last week. Akari Therapeutics was the among the top gainers in the healthcare sector, gaining 255.45% yesterday.

Akari Therapeutics shares are trading higher after the company announced preclinical data demonstrating synergistic activity of AKTX-101 with KRAS inhibition in KRAS-mutated pancreatic cancer models

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 57, which is 42 points higher than the healthcare sector average of 15. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has dropped -68.4% in the past year. It has underperformed other stocks in the healthcare sector by -9 percentage points.

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 86, which is 71 points higher than the healthcare sector average of 15. It passed 6 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has gained 532.26% in the past year. It has overperformed other stocks in the healthcare sector by 591 percentage points.

3. Auna Sa (NYSE:AUNA)

Auna Sa (NYSE:AUNA) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Auna Sa has a valuation score of 43, which is 28 points higher than the healthcare sector average of 15. It passed 3 out of 7 valuation due diligence checks.

Auna Sa's stock has dropped -36.8% in the past year. It has overperformed other stocks in the healthcare sector by 22 percentage points.

Are healthcare stocks a good buy now?

60.49% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 39.89% over the next year.

4.95% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.38% of healthcare stocks are rated B (Buy), 48.14% are rated C (Hold), 27.48% are rated D (Sell), and 7.05% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 27.77x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Indivior Pharmaceuticals (NASDAQ:INDV)

1. Cryo Cell International (NYSEMKT:CCEL)

2. So Young International (NASDAQ:SY)

3. Dominari Holdings (NASDAQ:DOMH)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Auna Sa (NYSE:AUNA)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Indivior Pharmaceuticals (NASDAQ:INDV)

1. Cryo Cell International (NYSEMKT:CCEL)

2. So Young International (NASDAQ:SY)

3. Dominari Holdings (NASDAQ:DOMH)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Auna Sa (NYSE:AUNA)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.